According to the research report titled ‘United States Non-Invasive Prenatal Testing Market 2019 – 2026’, available with MarketStudyReport, United States non-invasive prenatal market is estimated to grow at 13% CAGR during the forecast period 2019-2026.
 

As per the report findings, growth of United States non-invasive prenatal testing market is booted by rising per capita income, surging incidences of chromosomal aneuploidies among fetus, and development of advanced non-invasive testing products.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2132979/
 

For the unversed, non-invasive prenatal testing (NIPT) is a method used to determine the risk of a fetus being born with genetic abnormalities. It analyzes minute fragments of DNA circulating in the blood of a pregnant woman.
 

Increasing emphasis on reimbursement for this testing method, growing preference for non-invasive techniques over invasive procedures, and ACOG guidelines favoring NIPT for all pregnancies despite the risk involved are augmenting the industry outlook.
 

On the contrary, shortage of skilled professionals is likely to hamper the remuneration scope of United States non-invasive prenatal testing market in the ensuing years.
 

Apart from enlisting the drivers and restraints influencing the industry progress, the report entails a comparative study of historical data of 2015-2018 and current trends in order to predict the overall valuation by the year 2026. It further assesses the various segments and sub segments to illustrate the accurate size and scope of the marketplace.
 

Agilent Technologies, Inc., PerkinElmer, Inc., Progenity, Inc., Genpath, Inc., Otogenetics Corporation, Invitae Corporation, Centogene AG, Myriad Genetics, Inc., Quest Diagnostics, Inc., Natera, Inc., Illumina, Inc., Ariosa Diagnostics, Inc., and Esoterix Genetics Laboratories LLC are the major players profiled in the research document.
 

The aforementioned companies are undertaking effective strategies like collaborations, partnerships, new product launches, mergers & acquisitions, R&D investments, among others to further strengthen their foothold in United States non-invasive prenatal testing market.
 

Lastly, the study also evaluates each of the market players based on parameters like product outlook, business overview, and latest developments.